Skip to main content
. 2019 Nov 12;8(22):e012655. doi: 10.1161/JAHA.119.012655

Figure 3.

Figure 3

Adjusted odds ratios (and 95% CIs) for dose modification of renin–angiotensin–aldosterone system inhibitors, stratified by serum potassium (K+) threshold for CKD patients (A) and HF patients (B). An odds ratio of 1 (dotted line) indicates the odds of discontinuation or down‐titration under the defined threshold.